Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DAVID F. Archer

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Menopause (New York, N.Y.)|January 9, 2014
Vaginal cytokines do not differ between postmenopausal women with and without symptoms of vulvovaginal irritationPetra Stute, Zahraa Kollmann, Nick Bersinger, et al.
Contraception|May 16, 2009
Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implantShumei Zhao, Chainarong Choksuchat, Yueqin Zhao, et al.
Menopause (New York, N.Y.)|November 26, 2014
Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceDavid F Archer, Bruce R Carr, JoAnn V Pinkerton, et al.
Fertility and Sterility|April 28, 2009
Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual functionGeorge Kovalevsky, Susan A Ballagh, Frank Z Stanczyk, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 7, 2015
Vaginal cytokines do not correlate with postmenopausal vulvovaginal symptomsZahraa Kollmann, Nick Bersinger, Michael von Wolff, et al.
Menopause (New York, N.Y.)|January 9, 2020
Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR)Sebastian Mirkin, Steven R Goldstein, David F Archer, et al.
Menopause (New York, N.Y.)|June 1, 2006
Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal womenMark Naunton, Asmar F Y Al Hadithy, Jacobus R B J Brouwers, et al.
Menopause (New York, N.Y.)|July 13, 2016
Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical dataGinger D Constantine, David F Archer, Ricki Pollycove, et al.
Human Reproduction (Oxford, England)|August 8, 2006
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleedingRongxiu Li, Xiaoping Luo, Qun Pan, et al.
Plos One|December 27, 2022
Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic modelFrank Z Stanczyk, David F Archer, Lauren R L Lohmer, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Menopause (New York, N.Y.)|January 9, 2014
Vaginal cytokines do not differ between postmenopausal women with and without symptoms of vulvovaginal irritationPetra Stute, Zahraa Kollmann, Nick Bersinger, et al.
Contraception|May 16, 2009
Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implantShumei Zhao, Chainarong Choksuchat, Yueqin Zhao, et al.
Menopause (New York, N.Y.)|November 26, 2014
Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceDavid F Archer, Bruce R Carr, JoAnn V Pinkerton, et al.
Fertility and Sterility|April 28, 2009
Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual functionGeorge Kovalevsky, Susan A Ballagh, Frank Z Stanczyk, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 7, 2015
Vaginal cytokines do not correlate with postmenopausal vulvovaginal symptomsZahraa Kollmann, Nick Bersinger, Michael von Wolff, et al.
Menopause (New York, N.Y.)|January 9, 2020
Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR)Sebastian Mirkin, Steven R Goldstein, David F Archer, et al.
Menopause (New York, N.Y.)|June 1, 2006
Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal womenMark Naunton, Asmar F Y Al Hadithy, Jacobus R B J Brouwers, et al.
Menopause (New York, N.Y.)|July 13, 2016
Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical dataGinger D Constantine, David F Archer, Ricki Pollycove, et al.
Human Reproduction (Oxford, England)|August 8, 2006
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleedingRongxiu Li, Xiaoping Luo, Qun Pan, et al.
Plos One|December 27, 2022
Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic modelFrank Z Stanczyk, David F Archer, Lauren R L Lohmer, et al.
Pageof 18